Novel Therapeutic Approaches for the Treatment of MDS-Associated Anemia

Download this expert-selected slide set on optimal treatments for MDS-associated anemia.
Jamile Shammo, MD, FASCP, FACP
Format: Microsoft PowerPoint (.ppt)
File Size: 3.25 MB
Released: December 4, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Taiho Oncology Inc.

Related Content

Experts answer FAQ on key issues in the management of multiple myeloma

Brian G.M. Durie, MD Shaji Kumar, MD Thomas G. Martin, MD Philippe Moreau, MD S. Vincent Rajkumar, MD Jesús F. San-Miguel, MD, PhD Released: January 27, 2021

From Clinical Care Options, download slides reviewing the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Gain key clinical insights quickly with this short slideset from Clinical Care Options (CCO) on the integration of CAR T-cell therapy into community care

Michael R. Bishop, MD Jae H. Park, MD Released: January 26, 2021

Brief expert video from Clinical Care Options (CCO) on recommended treatment strategies for patients with myelodysplastic syndrome (MDS) and thrombocytopenia

Rami S. Komrokji, MD Physicians: maximum of 0.25 AMA PRA Category 1 Credits Registered Nurses: 0.25 Nursing contact hours Pharmacists: 0.25 contact hours (0.025 CEUs) Released: January 21, 2021 Expired: January 20, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue